RK

Rama Krishna Mamidi

Active Director Director DIN 09627905
DIN 09627905 First appointment Jun 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value •••• Premium profile

About Rama Krishna Mamidi

Data last updated:

Rama Krishna Mamidi is a Director at Metan Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Metan Pharmaceuticals Private Limited reported revenue of ₹31.3 Lakh (FY 2025).

DIN 09627905
Primary Designation Director
Industry Chemicals
First Appointment 01 Jun 2022
Oldest Company Age 4 yrs
Largest company Metan Pharmaceuticals Private Limited · ₹31.3 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20222022₹31.3 Lakh (FY 2025)Active

Board colleagues of Rama Krishna Mamidi

NameDINCompanyDesignation
Viswanath Mallela09035512Metan Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Metan Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rama Krishna Mamidi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rama Krishna Mamidi

Rama Krishna Mamidi currently holds 1 directorship: Metan Pharmaceuticals Private Limited (Director, since 01 Jun 2022, revenue ₹31.3 Lakh (FY 2025)).

Rama Krishna Mamidi was first appointed on 01 Jun 2022 as Director at Metan Pharmaceuticals Private Limited.

The current boards of Rama Krishna Mamidi's companies include Viswanath Mallela (Metan Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available